These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24146924)

  • 1. First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries.
    Hillemann D; Hoffner S; Cirillo D; Drobniewski F; Richter E; Rüsch-Gerdes S; ; ;
    PLoS One; 2013; 8(10):e76765. PubMed ID: 24146924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China.
    Jiang GL; Chen X; Song Y; Zhao Y; Huang H; Kam KM
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1491-4. PubMed ID: 24125456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
    Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV; Malakhov VN; Hoffner SE; Haile M; Wright A
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
    Tuberculosis Research Committee
    Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.
    Shu W; Du J; Liu Y; Wang Y; Huo F; Jiang G; Li L; Pang Y
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):871-875. PubMed ID: 31898799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter research on the BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China.
    Zhao LL; Liang YP; Huang MX; Tan YH; Jiang Y; Chen Y; Liu Z; Gao M; Wei S; Chen Z; Wu J; Jiang Y; Wan KL
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):330-4. PubMed ID: 24091105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.
    Fattorini L; Iona E; Cirillo D; Migliori GB; Orefici G; Aziz M; Wright A; Tafaj S; Baig B; Mulliqi G; Maungate S; Cuna Z; Al-Busaidy S; Al-Suwaidi Z; Ceyhan I
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):214-7. PubMed ID: 18230256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.
    Cambau E; Viveiros M; Machado D; Raskine L; Ritter C; Tortoli E; Matthys V; Hoffner S; Richter E; Perez Del Molino ML; Cirillo DM; van Soolingen D; Böttger EC
    J Antimicrob Chemother; 2015 Mar; 70(3):686-96. PubMed ID: 25587993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
    Şimşek H; Tarhan G; Cesur S
    Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic-Baltic collaboration.
    Johansen IS; Larsen AR; Sandven P; Petrini B; Soini H; Levina K; Sosnovskaja A; Skenders G; Hoffner S
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):899-902. PubMed ID: 12971676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai.
    Chen Y; Yuan Z; Shen X; Wu J; Wu Z; Xu B
    Biomed Res Int; 2016; 2016():2628913. PubMed ID: 27652260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
    Lin SY; Desmond E; Bonato D; Gross W; Siddiqi S
    J Clin Microbiol; 2009 Nov; 47(11):3630-4. PubMed ID: 19741086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.